ONC describes a class of investigational oral anticancer agents, including ONC201 and ONC207, which function as selective antagonists targeting specific cellular pathways involved in tumor growth. These… Read more
ONC describes a class of investigational oral anticancer agents, including ONC201 and ONC207, which function as selective antagonists targeting specific cellular pathways involved in tumor growth. These compounds are currently under research for their potential in treating various malignancies. Pharmaceutical laboratories rely on the high-quality reference standards within this category to support rigorous analytical testing and quality control. The collection includes structural impurities essential for comprehensive impurity profiling during drug development, as well as stable isotope labelled compounds such as deuterated standards. These labelled analogues serve as critical internal standards for mass spectrometry-based bioanalytical assays, ensuring accurate quantification and method validation. By utilizing these precise analytical tools, researchers can effectively monitor drug degradation, identify related substances, and maintain compliance with regulatory standards throughout the lifecycle of these therapeutic candidates.